Respiratory recovery trajectories after severe-to-critical COVID-19: a 1-year prospective multicentre study - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue European Respiratory Journal Année : 2023

Respiratory recovery trajectories after severe-to-critical COVID-19: a 1-year prospective multicentre study

Frédéric Schlemmer
Clairelyne Dupin
Anne Bergeron
  • Fonction : Auteur
Valentine Bonnefoy
  • Fonction : Auteur
Hélène Goussault
  • Fonction : Auteur
Maria Chiara Mennitti
  • Fonction : Auteur
Mehdi Roumila
  • Fonction : Auteur
Charlotte Colin
  • Fonction : Auteur
Sven Günther
  • Fonction : Auteur
Olivier Sanchez
  • Fonction : Auteur
Thomas Gille
Lucile Sésé
  • Fonction : Auteur
Yurdagul Uzunhan
Morgane Faure
  • Fonction : Auteur
Maxime Patout
Capucine Morelot-Panzini
  • Fonction : Auteur
Pierantonio Laveneziana
Violaine Giraud
  • Fonction : Auteur
Etienne Giroux-Leprieur
  • Fonction : Auteur
Stéfanie Habib
  • Fonction : Auteur
Nicolas Roche
  • Fonction : Auteur
Anh Tuan Dinh-Xuan
Islem Sifaoui
  • Fonction : Auteur
Pierre-Yves Brillet
  • Fonction : Auteur
Camille Jung
  • Fonction : Auteur
Emmanuelle Boutin
  • Fonction : Auteur
Richard Layese
  • Fonction : Auteur
Florence Canoui-Poitrine
  • Fonction : Auteur
Bernard Maitre
  • Fonction : Auteur

Résumé

Background Survivors of severe-to-critical COVID-19 may have functional impairment, radiological sequelae and persistent symptoms requiring prolonged follow-up. This pragmatic study aimed to describe their clinical follow-up and determine their respiratory recovery trajectories, and factors that could influence them and their health-related quality of life. Methods Adults hospitalised for severe-to-critical COVID-19 were evaluated at 3 months and up to 12 months post-hospital discharge in this prospective, multicentre, cohort study. Results Among 485 enrolled participants, 293 (60%) were reassessed at 6 months and 163 (35%) at 12 months; 89 (51%) and 47 (27%) of the 173 ones initially managed with standard oxygen were reassessed at 6 and 12 months, respectively. At 3 months, 34%, 70% and 56% of the participants had a restrictive lung defect, impaired DL CO and significant radiological sequelae, respectively. During extended follow-up, DL CO and FVC (% of predicted value) increased by means of +4 points at 6 months, and +6 points at 12 months. Sex, body mass index, chronic respiratory disease, immunosuppression, pneumonia extent or corticosteroid use during acute COVID-19 and prolonged invasive mechanical ventilation (IMV) were associated with DL CO at month 3, but not its trajectory thereafter. Among 475 (98%) patients with at least one chest computed-tomography scan during follow-up, 196 (41%) had significant sequelae on their last images. Conclusion Although pulmonary function and radiological abnormalities improved up to 1 year post-acute-COVID-19, high percentages of severe-to-critical disease survivors, including a notable proportion of those managed with standard oxygen, had significant lung sequelae and residual symptoms justifying prolonged follow-up.

Dates et versions

hal-03958196 , version 1 (26-01-2023)

Identifiants

Citer

Frédéric Schlemmer, Simon Valentin, Laurent Boyer, Anne Guillaumot, François Chabot, et al.. Respiratory recovery trajectories after severe-to-critical COVID-19: a 1-year prospective multicentre study. European Respiratory Journal, 2023, pp.2201532. ⟨10.1183/13993003.01532-2022⟩. ⟨hal-03958196⟩
62 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook Twitter LinkedIn More